Logo image of ACAN.PA

ACANTHE DEVELOPPEMENT SA (ACAN.PA) Stock Fundamental Analysis

EPA:ACAN - Euronext Paris - Matif - FR0000064602 - REIT - Currency: EUR

0.337  0 (-1.17%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ACAN. ACAN was compared to 43 industry peers in the Diversified REITs industry. While ACAN has a great health rating, there are worries on its profitability. ACAN is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year ACAN has reported negative net income.
ACAN had a positive operating cash flow in the past year.
In multiple years ACAN reported negative net income over the last 5 years.
ACAN had a positive operating cash flow in 4 of the past 5 years.
ACAN.PA Yearly Net Income VS EBIT VS OCF VS FCFACAN.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M

1.2 Ratios

With a Return On Assets value of -10.18%, ACAN is not doing good in the industry: 86.05% of the companies in the same industry are doing better.
ACAN has a worse Return On Equity (-12.76%) than 83.72% of its industry peers.
Industry RankSector Rank
ROA -10.18%
ROE -12.76%
ROIC N/A
ROA(3y)-0.22%
ROA(5y)0.72%
ROE(3y)-0.39%
ROE(5y)1%
ROIC(3y)N/A
ROIC(5y)N/A
ACAN.PA Yearly ROA, ROE, ROICACAN.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20

1.3 Margins

ACAN has a Gross Margin of 72.73%. This is comparable to the rest of the industry: ACAN outperforms 48.84% of its industry peers.
ACAN's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for ACAN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 72.73%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.47%
GM growth 5Y1.35%
ACAN.PA Yearly Profit, Operating, Gross MarginsACAN.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200 -200 400 600 800

7

2. Health

2.1 Basic Checks

ACAN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ACAN remains at a similar level compared to 1 year ago.
The number of shares outstanding for ACAN remains at a similar level compared to 5 years ago.
Compared to 1 year ago, ACAN has a worse debt to assets ratio.
ACAN.PA Yearly Shares OutstandingACAN.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M
ACAN.PA Yearly Total Debt VS Total AssetsACAN.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

2.2 Solvency

ACAN has an Altman-Z score of 2.03. This is not the best score and indicates that ACAN is in the grey zone with still only limited risk for bankruptcy at the moment.
ACAN has a Altman-Z score of 2.03. This is amongst the best in the industry. ACAN outperforms 97.67% of its industry peers.
The Debt to FCF ratio of ACAN is 0.19, which is an excellent value as it means it would take ACAN, only 0.19 years of fcf income to pay off all of its debts.
ACAN has a Debt to FCF ratio of 0.19. This is amongst the best in the industry. ACAN outperforms 100.00% of its industry peers.
A Debt/Equity ratio of 0.01 indicates that ACAN is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.01, ACAN belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.19
Altman-Z 2.03
ROIC/WACCN/A
WACC7.89%
ACAN.PA Yearly LT Debt VS Equity VS FCFACAN.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M 150M

2.3 Liquidity

ACAN has a Current Ratio of 1.64. This is a normal value and indicates that ACAN is financially healthy and should not expect problems in meeting its short term obligations.
ACAN has a better Current ratio (1.64) than 88.37% of its industry peers.
ACAN has a Quick Ratio of 1.64. This is a normal value and indicates that ACAN is financially healthy and should not expect problems in meeting its short term obligations.
ACAN has a better Quick ratio (1.64) than 93.02% of its industry peers.
Industry RankSector Rank
Current Ratio 1.64
Quick Ratio 1.64
ACAN.PA Yearly Current Assets VS Current LiabilitesACAN.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

0

3. Growth

3.1 Past

The earnings per share for ACAN have decreased strongly by -290.04% in the last year.
Looking at the last year, ACAN shows a small growth in Revenue. The Revenue has grown by 3.21% in the last year.
Measured over the past years, ACAN shows a decrease in Revenue. The Revenue has been decreasing by -4.97% on average per year.
EPS 1Y (TTM)-290.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1309.09%
Revenue 1Y (TTM)3.21%
Revenue growth 3Y-6.38%
Revenue growth 5Y-4.97%
Sales Q2Q%-0.9%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ACAN.PA Yearly Revenue VS EstimatesACAN.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
ACAN.PA Yearly EPS VS EstimatesACAN.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

1

4. Valuation

4.1 Price/Earnings Ratio

ACAN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ACAN.PA Price Earnings VS Forward Price EarningsACAN.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ACAN is valued a bit more expensive than 74.42% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ACAN indicates a somewhat cheap valuation: ACAN is cheaper than 79.07% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 8.49
EV/EBITDA 217.14
ACAN.PA Per share dataACAN.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 32.26%, ACAN is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 8.60, ACAN pays a better dividend. On top of this ACAN pays more dividend than 97.67% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.33, ACAN pays a better dividend.
Industry RankSector Rank
Dividend Yield 32.26%

5.2 History

The dividend of ACAN is nicely growing with an annual growth rate of 63.85%!
Dividend Growth(5Y)63.85%
Div Incr Years1
Div Non Decr Years1
ACAN.PA Yearly Dividends per shareACAN.PA Yearly Dividends per shareYearly Dividends per share 2019 2023 2024 0.01 0.02 0.03 0.04 0.05

5.3 Sustainability

The earnings of ACAN are negative and hence is the payout ratio. ACAN will probably not be able to sustain this dividend level.
DP-159.58%
EPS Next 2YN/A
EPS Next 3YN/A
ACAN.PA Yearly Income VS Free CF VS DividendACAN.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M 60M

ACANTHE DEVELOPPEMENT SA

EPA:ACAN (3/7/2025, 7:00:00 PM)

0.337

0 (-1.17%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)09-26 2024-09-26
Earnings (Next)04-23 2025-04-23
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners49.25%
Ins Owner ChangeN/A
Market Cap55.72M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 32.26%
Yearly Dividend0.15
Dividend Growth(5Y)63.85%
DP-159.58%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 14.11
P/FCF 8.49
P/OCF 8.27
P/B 0.51
P/tB 0.51
EV/EBITDA 217.14
EPS(TTM)-0.09
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.04
FCFY11.78%
OCF(TTM)0.04
OCFY12.1%
SpS0.02
BVpS0.66
TBVpS0.66
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -10.18%
ROE -12.76%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 72.73%
FCFM 166.22%
ROA(3y)-0.22%
ROA(5y)0.72%
ROE(3y)-0.39%
ROE(5y)1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.47%
GM growth 5Y1.35%
F-Score3
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.19
Debt/EBITDA 6
Cap/Depr 2.11%
Cap/Sales 4.51%
Interest Coverage N/A
Cash Conversion 3225.84%
Profit Quality N/A
Current Ratio 1.64
Quick Ratio 1.64
Altman-Z 2.03
F-Score3
WACC7.89%
ROIC/WACCN/A
Cap/Depr(3y)109.71%
Cap/Depr(5y)141.3%
Cap/Sales(3y)9.92%
Cap/Sales(5y)17.92%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-290.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1309.09%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.21%
Revenue growth 3Y-6.38%
Revenue growth 5Y-4.97%
Sales Q2Q%-0.9%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-440.3%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y129.23%
FCF growth 3Y97.78%
FCF growth 5YN/A
OCF growth 1Y130.47%
OCF growth 3Y88.64%
OCF growth 5YN/A